The Making of a New Disease

Think back: When did you first hear the phrase metabolic syndrome? When did it start to become part of your business and its plans? Maybe that second step hasn't taken place yet. But for many in pharma it's coming soon. In the past few years, scientists, researchers, and healthcare companies have been paying increasing attention to the concept that obesity, hyperlipidemia, diabetes, and hypertension-and perhaps other diseases, including some cancers-are linked.

For full article Click Here